Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Scientific Industries (SCND) Cash & Equivalents (2016 - 2025)

Scientific Industries (SCND) has 16 years of Cash & Equivalents data on record, last reported at $7.1 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 1165.5% year-over-year to $7.1 million; the TTM value through Sep 2025 reached $7.1 million, up 1165.5%, while the annual FY2024 figure was $587900.0, 26.15% down from the prior year.
  • Cash & Equivalents reached $7.1 million in Q3 2025 per SCND's latest filing, up from $891400.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $11.8 million in Q1 2022 and bottomed at $351700.0 in Q1 2024.
  • Average Cash & Equivalents over 5 years is $2.8 million, with a median of $891400.0 recorded in 2025.
  • Peak YoY movement for Cash & Equivalents: soared 1786.31% in 2022, then plummeted 90.88% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $4.3 million in 2021, then plummeted by 55.15% to $1.9 million in 2022, then tumbled by 58.69% to $796100.0 in 2023, then dropped by 26.15% to $587900.0 in 2024, then soared by 1112.98% to $7.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $7.1 million in Q3 2025, $891400.0 in Q2 2025, and $470100.0 in Q1 2025.